Three years of promise, proposals, and progress on optimizing the benefit/risk of medicines: a commentary on the 3rd FDA-DIA-PWG-PhRMA-BIO pharmacogenomics workshop.

Autor: Salerno, R. A.1 salernr@wyeth.com, Lesko, L. J.2 leskol@cder.fda.gov
Zdroj: Pharmacogenomics Journal. 2006, Vol. 6 Issue 2, p78-81. 4p.
Databáze: Academic Search Ultimate